2-[(4-methyl-4h-1,2,4-triazol-3-yl)sulfanyl]aniline, 97%, 100mg

5-Bromoindole-3-carboxaldehyde, 97.0%, 25g

(R)-benzyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate, 98%, 5g

GC capillary column ROTI®Cap-1701, 30 m, 0.25 mm, 0.50 µm, 1 Piece(s)

(R)-Morpholin-2-ylmethanol hydrochloride, 95.0%, 10g

1-(Bromomethyl)-2-(methylsulfonyl)benzene, 95.0%, 10g

4-(2-Amino-ethoxymethyl)-piperidine-1-carboxylic acid tert-butyl ester, 250mg

o-Acetanisidide>98.0%(HPLC)(N)25g

N-(2-sec-Butylphenyl)-2-chloropropanamide, 97%, 10g

CF-BI>98.0%(HPLC)25mg

8-Bromo-3,4-dihydro-2H-1,4-benzoxazine, 95.0%, 250mg

(S)-3,3'-Dibromo-2,2'-dimethoxy-1,1'-binaphthalene, 98.0%, 250mg

4-Nitropyridin-2-amine, 98.0%, 10g